Fig. 2.
Survival curves of 145 patients with B-CLL.
Comparisons were made of patients whose cells are CD38+(, n = 60) or CD− (●, n = 85) and have mutated (○, n = 95) or unmutated (▪, n = 50) IgVHgenes from date of diagnosis of CLL (A) or from date of CD38 estimation (B).